These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29882422)

  • 1. β-lactam antibiotics & vancomycin increase the growth & virulence of Candida spp.
    Aguiar Cordeiro R; de Jesus Evangelista AJ; Serpa R; Colares de Andrade AR; Leite Mendes PB; Silva Franco JD; de Oliveira JS; de Alencar LP; Sales JA; Carneiro Câmara LM; Souza Collares Maia Castelo-Branco D; Nogueira Brilhante RS; Costa Sidrim JJ; Gadelha Rocha MF
    Future Microbiol; 2018 Jun; 13():869-875. PubMed ID: 29882422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Lactam antibiotics and vancomycin inhibit the growth of planktonic and biofilm Candida spp.: an additional benefit of antibiotic-lock therapy?
    Sidrim JJ; Teixeira CE; Cordeiro RA; Brilhante RS; Castelo-Branco DS; Bandeira SP; Alencar LP; Oliveira JS; Monteiro AJ; Moreira JL; Bandeira TJ; Rocha MF
    Int J Antimicrob Agents; 2015 Apr; 45(4):420-3. PubMed ID: 25631674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.
    Silva LN; Campos-Silva R; Ramos LS; Trentin DS; Macedo AJ; Branquinha MH; Santos ALS
    FEMS Yeast Res; 2018 Nov; 18(7):. PubMed ID: 30052907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticandidal activity of biosynthesized silver nanoparticles: effect on growth, cell morphology, and key virulence attributes of Candida species.
    Jalal M; Ansari MA; Alzohairy MA; Ali SG; Khan HM; Almatroudi A; Siddiqui MI
    Int J Nanomedicine; 2019; 14():4667-4679. PubMed ID: 31308652
    [No Abstract]   [Full Text] [Related]  

  • 7. Resveratrol and its antifungal activity against Candida species.
    Weber K; Schulz B; Ruhnke M
    Mycoses; 2011 Jan; 54(1):30-3. PubMed ID: 19703269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence.
    Ortega-Riveros M; De-la-Pinta I; Marcos-Arias C; Ezpeleta G; Quindós G; Eraso E
    Mycopathologia; 2017 Oct; 182(9-10):785-795. PubMed ID: 28523422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
    Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propolis: a potential natural product to fight Candida species infections.
    Tobaldini-Valerio FK; Bonfim-Mendonça PS; Rosseto HC; Bruschi ML; Henriques M; Negri M; Silva S; Svidzinski TIe
    Future Microbiol; 2016 Aug; 11():1035-46. PubMed ID: 27501739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
    Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
    Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilm as a virulence marker in Candida species in Nosocomial blood stream infection and its correlation with antifungal resistance.
    Bhatt M; Sarangi G; Paty BP; Mohapatra D; Chayani N; Mahapatra A; Das P; Sahoo D
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():112-4. PubMed ID: 25657126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological investigation of non-albicans Candida species recovered from mycotic mastitis of cows in Yinchuan, Ningxia of China.
    Du J; Wang X; Luo H; Wang Y; Liu X; Zhou X
    BMC Vet Res; 2018 Aug; 14(1):251. PubMed ID: 30157847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antifungal activity of standardized extract of Salvia rhytidea Benth. (Lamiaceae) against various Candida isolates.
    Salari S; Bakhshi T; Sharififar F; Naseri A; Ghasemi Nejad Almani P
    J Mycol Med; 2016 Dec; 26(4):323-330. PubMed ID: 27499461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran.
    Razzaghi-Abyaneh M; Sadeghi G; Zeinali E; Alirezaee M; Shams-Ghahfarokhi M; Amani A; Mirahmadi R; Tolouei R
    J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen.
    Samaranayake YH; Samaranayake LP
    J Med Microbiol; 1994 Nov; 41(5):295-310. PubMed ID: 7966200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.